Southbank, Australia

Immuron Limited


USPTO Granted Patents = 5



Trademarks = 1

Forward Citations = 8

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Yaron Ilan (2 out of 47 patents)

silverMedal Ami Ben-Ya'Acov (2 out of 5 patents)

bronzeMedal Meir Mizrahi (2 out of 3 patents)

4.  Gadi Lalazar (2 out of 4 patents)

5.  Gottfried Lichti (2 out of 8 patents)

6.  Tomer Adar (2 out of 2 patents)

7.  Roy Michael Robins-Browne (2 out of 2 patents)

8.  Grant Thomas Rawlin (2 out of 2 patents)

9.  Dena Lyras (1 out of 2 patents)

10.  Melanie Hutton (1 out of 1 patent)

11.  Bliss Cunningham (1 out of 1 patent)

12.  Lucy Li (1 out of 1 patent)

13.  Glen Carter (1 out of 1 patent)

14.  Julian Rood (1 out of 3 patents)

15.  Ami Ben-Yaakov (1 patent)


5 patents:

Company Overview
Immuron Limited is an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of gut mediated diseases. The company's lead product, Travelan, is designed to prevent and treat travelers' diarrhea, and its pipeline includes products for fatty liver disease and NASH. Immuron is dedicated to improving global health through innovative therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#6 in Southbank

#797 in Australia

Southbank, AU
Southbank, Australia
Forward Citations = 8

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immuron Limited. Retrieved from https://idiyas.com/company/immuron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…